HTA & Evidence Requirements for Pharma & Biotech

HTA & Evidence Requirements for Pharma & Biotech

100% online

Training features

Fully online

no need to travel, just sit back, relax and enjoy the learning experience

On any device

you can log in via mobile, tablet or laptop

Flexible Schedule

start when you want and follow the course at your own pace

Continuous access

you will continue to have access to the course for 3 months after completing your registration

Conveniently designed video content

the course content is divided into shorter video lectures that will allow you to increase the attention span and improve the learning experience

Full slide deck

you will be able to download the full slide deck to support your learning

Certificate of completion

upon the completion of the course you will receive the certificate of completion signed by the course leader

Course description

This unique course provides a practical & in-depth understanding of HTA decision making across EU marketsand will focus on the evidence generation underpinning a convincing value proposition to different HTAs.It will provide the tools to understand and critically appraise the evidence and studies required for HTA submissions, and to be able to put together an evidence plan including the underpinning data requirements and understanding the role of patients, cost-effectiveness models, access schemes and scientific advice.

The training is structured in a way that participants can connect the strategic importance of process requirements to underlying methods and optimal evidence. The training offers practical insights of former payer decision makers, method specialists and direct experience from HTA dossier submission and defense in different HTA driven markets. While HTA methods and processes are likely to change in the 2020’s significantly and rapidly, this course will allow understanding of current practices, learning about future plans, and discussing potential changes in both process and requirements.

By completing this course you will get familiar with the strategies for patient access in an evolving value- based and patient-centric healthcare.

meet the training leaders
Susanne Michel MD, MSc
Ascenian Consulting, Germany
Noemi Muszbek MSc
Health Economics Director, Partner
Visible Analytics, UK
Edit Remak MSc, PhD
Health Economics Director, Partner
Visible Analytics, Hungary




Reveal the full schedule of the training as well as key topics, course objectives, key takeaways, special features, and the trainer bio!

HTA and Evidence Requirements Training Course organized by Fleming_Agenda Sneak Peek_1
HTA and Evidence Requirements Training Course organized by Fleming_Agenda Sneak Peek
key training


HTA decision making across EU markets

Requirements & evidence for HTA assessments

A value proposition from an HTA perspective

The role of patients in HTA decision-making

Optimizing the generation and the use of evidence in HTA

Cost-effectiveness model & budget impact

Handling uncertainty, access schemes & contracting

Scientific advice

HTA for cell & gene therapies

EU HTA pathway

Buy the Course Recording

Online Video Recording

Contact us